A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent
1
School of Engineering, University of Warwick, Coventry, United Kingdom
2
University of Wales College of Medicine, Cardiff University, Cardiff, United Kingdom
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 718; https://doi.org/10.3797/scipharm.cespt.8.POT03
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Topotecan (TPT) is a semi-synthetic derivative of the natural extract camptothecin, which has been found to act as an inhibitor of the DNA enzyme topoisomerase I in a specific and reversible fashion. [...]
Share and Cite
MDPI and ACS Style
ATARI, M.I.; CHAPPELL, M.J.; ERRINGTON, R.J.; SMITH, P.J.; EVANS, N.D. A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent. Sci. Pharm. 2010, 78, 718. https://doi.org/10.3797/scipharm.cespt.8.POT03
AMA Style
ATARI MI, CHAPPELL MJ, ERRINGTON RJ, SMITH PJ, EVANS ND. A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent. Scientia Pharmaceutica. 2010; 78(3):718. https://doi.org/10.3797/scipharm.cespt.8.POT03
Chicago/Turabian StyleATARI, M. I., M. J. CHAPPELL, R. J. ERRINGTON, P. J. SMITH, and N. D. EVANS. 2010. "A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent" Scientia Pharmaceutica 78, no. 3: 718. https://doi.org/10.3797/scipharm.cespt.8.POT03
